University Multiprofile Hospital For Active Treatment Eurohospital Plovdiv Ltd.

At University Multiprofile Hospital For Active Treatment Eurohospital Plovdiv Ltd., clinical research in cardiometabolic disease focuses on conditions such as severe hypertriglyceridemia and related metabolic risk. The trials are designed to evaluate new treatment options that may help control abnormal blood lipid levels and improve overall disease management.

• Studies in severe hypertriglyceridemia are assessing whether new therapies can lower triglyceride levels more effectively.
• Research in cardiovascular and metabolic disorders is aimed at improving long-term treatment outcomes.

These trials reflect a strong interest in better managing metabolic complications that can affect heart and vascular health.

Clinical trials in musculoskeletal disease at this site are centered on gout with hyperuricemia and axial spondyloarthritis, two conditions that can cause pain, inflammation, and reduced mobility. The research is exploring whether newer treatments can improve symptom control and disease activity compared with established care.

• Trials in gout are evaluating therapies intended to reduce uric acid and support better disease control.
• Studies in axial spondyloarthritis are testing options to improve signs, symptoms, and daily functioning.

This area highlights a practical effort to advance treatment for chronic inflammatory joint and spine disorders.

The site also conducts research on urgent bleeding-related conditions, especially in people taking factor Xa inhibitors who need emergency surgery or procedures. These studies aim to determine how well new approaches can restore hemostasis and help reduce bleeding risk in critical situations.

• Research is focused on reversing the anticoagulant effect of apixaban, rivaroxaban, and edoxaban.
• Trials are evaluating whether treatment can support safer urgent surgical care.

This work is especially relevant for improving emergency management when rapid bleeding control is needed.

Research at the Department internal diseases includes studies in post-menopausal osteoporosis, a condition linked to bone loss and fracture risk after menopause. The trials are intended to assess whether new bone-directed therapies can match established treatment in supporting bone health and reducing markers of bone breakdown.

• Studies in post-menopausal osteoporosis are examining bone mineral density and treatment performance.
• These trials are designed to compare the effectiveness and safety of alternative osteoporosis therapies.

This research supports better options for maintaining bone strength in older women.

Across its clinical trial portfolio, the hospital is investigating therapies for metabolic and inflammatory disorders that affect both body chemistry and physical function. The research spans conditions such as gout, hypertriglyceridemia, and osteoporosis, with the goal of improving treatment effectiveness and expanding options for patients.

• Trials are testing whether new medicines can better control uric acid and lipid abnormalities.
• Other studies are comparing emerging therapies with standard care to improve disease control and patient outcomes.

With 5 clinical trials and 11 investigators, the site shows a focused research effort in chronic disease management.